InvestorsHub Logo
Followers 56
Posts 8435
Boards Moderated 0
Alias Born 05/14/2015

Re: TREND1 post# 12822

Sunday, 07/05/2015 10:02:39 AM

Sunday, July 05, 2015 10:02:39 AM

Post# of 32013
I know everyone wants to compare the two because Exubera was an inhaled insulin, but they aren't competing head to head. different time different situation. The reason why Afrezza is ridiculed is because of Exubera's failure. You know the two are nothing alike and you know that SNY has deliberately planned a calculated slow launch for Afrezza. So why ignore those facts? You seem to think SNY doesn't know what they are doing. It is too early to say if Afrezza is a failure. And comparing it to Exubera is disingenuous.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News